MedPath

Cognitive Behaviour Therapy: Treatment Administered Via Videoconference Versus In-Perso

Not Applicable
Recruiting
Conditions
In accordance with the Diagnositic Statistical Manual of mental disorder-4th edition, participants will have to meet the criteria for a diagnosis on the depression and anxiety spectrum, which includes but not limited to
depression, dysthymia, generalized anxiety disorder, panic disorder with and without agoraphobia, social phobia, specific phobia, obsessive-compulsive disorder and post-traumatic stress disorder.
Mental Health - Depression
Mental Health - Anxiety
Registration Number
ACTRN12609000819224
Lead Sponsor
Curtin University of Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
115
Inclusion Criteria

Diagnostic Statistical Manual for mental disorder (4th Edition): diagnosis on the depression and anxiety spectrum, which includes but not limited to; depression, dysthymia, generalized anxiety disorder, panic disorder with and without agoraphobia, social phobia, specific phobia, OCD and PTSD.

Exclusion Criteria

Anorexia, Personality disorder as the primary diagnosis, Self-harming/suicidal, Involved in legal proceedings, Psychosis (past or present)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the efficacy of cognitive behavioural psychotherapy via videoconference. <br><br>Structured Interview For the DSM-IV- will be used for assessmetn and diagnosis. <br>Primary Measures:<br>Depression Anxiety Stress scale (DASS)<br>Quality Of Life & Satisfaction Questionnaire (Q-LES)<br>This will assessed by using a 2x3 (VC-F2F x pre-post-follow up) Analysis of Covariance.[November 2009- January 2011<br><br>All participants will be treated within this period. When their assessment/diagnosis occurs depend on when they are referred to the Curtin Psychology Clinic. The questionnaires used on the day of the first assessment will constitute the pre-treatment measure. Treatment will be conducted for a maximum of 12 weeks. Measures administered at the start of treatment will also be provided at the end of treatment (post-treatment data). Then 6-weeks after treatment has ended the same questionnaires will be given to participants, which will constitute the follow-up data.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath